An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects
Clinical trial NCT02427607 · COMPLETED
Trial details
- NCT number
- NCT02427607
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-12
- Primary completion
- 2016-09-21
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.